{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T13:54:07Z","timestamp":1684850047322},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anaesthesist"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1007\/s00101-005-0897-z","type":"journal-article","created":{"date-parts":[[2005,8,17]],"date-time":"2005-08-17T16:15:04Z","timestamp":1124295304000},"page":"957-974","source":"Crossref","is-referenced-by-count":5,"title":["Das akute Koronarsyndrom in der Pr\u00e4hospitalphase"],"prefix":"10.1007","volume":"54","author":[{"given":"J.-H.","family":"Schiff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. R.","family":"Arntz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. W.","family":"B\u00f6ttiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"897_CR1","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1053\/euhj.2001.2750","volume":"22","author":"Akkerhuis","year":"2001","unstructured":"Akkerhuis KM, Klootwijk PA, Lindeboom W, Umans VA, Meij S, Kint P, Simoons ML (2001) Recurrent ischaemia during continuous multilead St-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events; meta-analysis of three studies involving 995 patients. Eur Heart J 22:1997\u20132006","journal-title":"Eur Heart J"},{"key":"897_CR2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM199501123320203","volume":"332","author":"Ambrosioni","year":"1995","unstructured":"Ambrosioni E, Borghi C, Magnani B (1995) The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction: the Survival of Myocardial Infarction: Long-Term Evaluation (SMILE) Study Investigators. N Engl J Med 332:80\u201385","journal-title":"N Engl J Med"},{"key":"897_CR3","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0140-6736(02)11278-5","volume":"360","author":"Antman","year":"2002","unstructured":"Antman EM (2002) Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial. Lancet 360:1189\u20131196","journal-title":"Lancet"},{"key":"897_CR4","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/01.CIR.86.3.764","volume":"86","author":"Antman","year":"1992","unstructured":"Antman EM, Berlin JA (1992) Declining incidence of ventricular fibrillation in myocardial infarction. Implications for the prophylactic use of lidocaine. Circulation 86:764\u2013773","journal-title":"Circulation"},{"key":"897_CR5","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/01.CIR.100.15.1593","volume":"100","author":"Antman","year":"1999","unstructured":"Antman EM, McCabe CH, Gurfinkel EP et al. (1999) Enoxaparin prevents death and cardiac ischemic events in unstable angina\/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation 100:1593\u20131601","journal-title":"Circulation"},{"key":"897_CR6","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1161\/01.CIR.100.15.1602","volume":"100","author":"Antman","year":"1999","unstructured":"Antman EM, Cohen M, Radley D et al. (1999) Assessment of the treatment effect of enoxaparin for unstable angina\/non-Q-wave myocardial infarction: TIMI 11B-ESSENCE metaanalysis. Circulation 100:1602\u20131608","journal-title":"Circulation"},{"key":"897_CR7","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/01.CIR.0000134791.68010.FA","volume":"110","author":"Antman","year":"2004","unstructured":"Antman EM, Anbe DT, Armstrong PW et al. (2004) ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction. Circulation 110:588\u2013636","journal-title":"Circulation"},{"key":"897_CR8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","volume":"308","author":"Antiplatelet","year":"1994","unstructured":"Antiplatelet Trialists\u2018 Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308:81\u2013106","journal-title":"BMJ"},{"key":"897_CR9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic","year":"2002","unstructured":"Antithrombotic Trialists\u2018 Collaboration (2002) Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324:71\u201386","journal-title":"BMJ"},{"key":"897_CR10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0002-9149(92)91182-4","volume":"80","author":"Arntz","year":"1992","unstructured":"Arntz HR, Stern R, Linderer T (1992) Efficiency of a physician-operated mobile intensive care unit for prehospital thrombolysis in acute myocardial infarction. Am J Cardiol 80:417\u2013420","journal-title":"Am J Cardiol"},{"key":"897_CR11","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s003920050499","volume":"89","author":"Arntz","year":"2000","unstructured":"Arntz HR, Tebbe U, Schuster HP, Sauer G, Meyer J (2000) Leitlinien zur Diagnostik und Therapie des akuten Herzinfarkts in der Pr\u00e4hospitalphase. Z Kardiol 89:364\u2013370","journal-title":"Z Kardiol"},{"key":"897_CR12","first-page":"327","volume":"24","author":"Aronow","year":"1998","unstructured":"Aronow WS (1998) Use of beta-bockers during and after myocardial infarction. Comp Ther 24:327\u2013331","journal-title":"Comp Ther"},{"key":"897_CR13","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0140-6736(99)07403-6","volume":"354","author":"ASSENT-2","year":"1999","unstructured":"ASSENT-2: Assessment of the Safety and Efficacy of a New Thrombolytic Investigators (1999) Singlebolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet 354:716\u2013722","journal-title":"Lancet"},{"key":"897_CR14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1017\/S1049023X00042904","volume":"11","author":"Aufderheide","year":"1996","unstructured":"Aufderheide TP, Kereiakes DJ, Weaver WD, Gibler WB, Simoons ML (1996) Planning, implementation and process monitoring for prehospital 12-lead ECG diagnostic programs. Prehospital Disaster Med 11:162\u2013171","journal-title":"Prehospital Disaster Med"},{"key":"897_CR15","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1053\/euhj.2002.3385","volume":"23","author":"Bertrand","year":"2002","unstructured":"Bertrand ME, Simoons ML, Fox KAA et al. (2002) Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 23:1809\u20131840","journal-title":"Eur Heart J"},{"key":"897_CR16","first-page":"122","volume":"76","author":"Bippus","year":"1987","unstructured":"Bippus PH, Storch WH, Andresen D, Schr\u00f6der R (1987) Thrombolysis started at home in acute myocardial infarction: feasibility and time-gain. Circulation 76:122","journal-title":"Circulation"},{"key":"897_CR17","first-page":"79","volume":"27","author":"Bode","year":"1992","unstructured":"Bode WE (1992) Non-Q-wave myocardial infarction: a prognostic paradox. Hosp Pract 27:79\u201392","journal-title":"Hosp Pract"},{"key":"897_CR18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(96)02514-7","volume":"348","author":"Boersma","year":"1996","unstructured":"Boersma E, Maas A, Deckers J, Simons M (1996) Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 348:771\u2013775","journal-title":"Lancet"},{"key":"897_CR19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(02)09963-4","volume":"360","author":"Bonnefoy","year":"2002","unstructured":"Bonnefoy E, Lapostolle F, Leizorovicz A et al. (2002) Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Comparison of Angioplasty and Prehospital Thrombolysis in Acute Myocardial Infarction (CAPTIM) Study Group. Lancet 360:825\u2013829","journal-title":"Lancet"},{"key":"897_CR20","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/hrt.82.6.674","volume":"82","author":"B","year":"1999","unstructured":"B\u00f6ttiger BW, Grabner C, Bauer H, Bode C, Weber T, Motsch J, Martin E (1999) Long term outcome after out-of-hospital cardiac arrest with physician staffed emergency medical services: the Utstein style applied to a midsized urban\/suburban area. Heart 82:674\u2013679","journal-title":"Heart"},{"key":"897_CR21","first-page":"1583","volume":"357","author":"B","year":"2000","unstructured":"B\u00f6ttiger BW, Bode C, Kern S et al. (2000) Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet 357:1583\u20131585","journal-title":"Lancet"},{"key":"897_CR22","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1161\/01.CIR.0000030314.11999.6A","volume":"106","author":"Braunwald","year":"2002","unstructured":"Braunwald E, Antman EM, Beasley JW et al. (2002) American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). ACC\/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction \u2014 2002: summary article: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation 106:1893\u20131900","journal-title":"Circulation"},{"key":"897_CR23","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0735-1097(98)00134-X","volume":"31","author":"Brieger","year":"1998","unstructured":"Brieger DB, Mak KH, Kottke-Marchant K, Topol EJ (1998) Heparin-induced thrombocytopenia. J Am Coll Cardiol 31:1449\u20131459","journal-title":"J Am Coll Cardiol"},{"key":"897_CR24","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1056\/NEJM199705013361802","volume":"336","author":"Burke","year":"1997","unstructured":"Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R (1997) Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 336:1276\u20131282","journal-title":"N Engl J Med"},{"key":"897_CR25","first-page":"239","volume":"5","author":"Cairns","year":"1989","unstructured":"Cairns JA, Singer J, Gent M et al. (1989) One year mortality outcomes of all coronary and intensive care unit patients with acute myocardial infarction, unstable angina or other chest pain in Hamilton, Ontario, a city of 375,000 people. Can J Cardiol 5:239\u2013246","journal-title":"Can J Cardiol"},{"key":"897_CR26","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1161\/01.CIR.98.25.2805","volume":"98","author":"Cannon","year":"1998","unstructured":"Cannon CP, Gibson CM, McCabe CH et al. (1998) TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators. Circulation 98:2805\u20132814","journal-title":"Circulation"},{"key":"897_CR27","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJM200005253422106","volume":"342","author":"Canto","year":"2000","unstructured":"Canto JG, Every NR, Magid DJ et al. (2000) The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. N Engl J Med 342:1573\u20131580","journal-title":"N Engl J Med"},{"key":"897_CR28","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(96)10452-9","volume":"349","author":"CAPTURE","year":"1997","unstructured":"CAPTURE Investigators (1997) Randomised placebo-controlled trial of abciximab before and during intervention in refractory unstable angina: the CAPTURE study. Lancet 349:1429\u20131435","journal-title":"Lancet"},{"key":"897_CR29","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0735-1097(98)00325-8","volume":"32","author":"Casale","year":"1998","unstructured":"Casale PN, Jones JL, Wolf FE, Pei Y, Eby LM (1998) Patients treated by cardiologists have a lower in-hospital mortality for acute myocardial infarction. J Am Coll Cardiol 32:885\u2013889","journal-title":"J Am Coll Cardiol"},{"key":"897_CR30","doi-asserted-by":"crossref","first-page":"30A","DOI":"10.1016\/0002-9149(89)90927-2","volume":"64","author":"Castaigne","year":"1989","unstructured":"Castaigne AD, Herve C, Duval-Moulin AM et al. (1989) Prehospital use of APSAC: results of a placebo-controlled study. Am J Cardiol 64:30A\u201333A","journal-title":"Am J Cardiol"},{"key":"897_CR31","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0140-6736(95)90866-8","volume":"345","author":"CCS-1","year":"1995","unstructured":"CCS-1 (1995) Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study. Lancet 345:686\u2013687","journal-title":"Lancet"},{"key":"897_CR32","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1161\/01.CIR.96.11.3849","volume":"96","author":"Chambless","year":"1997","unstructured":"Chambless L, Keil U, Dobson A et al. (1997) Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985\u20131990. Multinational Monitoring of Trends and Determinants in Cardiovascular Disease. Circulation 96:3849\u20133859","journal-title":"Circulation"},{"key":"897_CR33","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0002-9149(97)00181-1","volume":"79","author":"Cohen","year":"1997","unstructured":"Cohen MC, Rohtla KM, Lavery CE, Muller JE, Mittleman MA (1997) Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol 79:1512\u20131516","journal-title":"Am J Cardiol"},{"key":"897_CR34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","volume":"337","author":"Cohen","year":"1997","unstructured":"Cohen M, Demers C, Gurfinkel EP et al. (1997) A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med 337:447\u2013452","journal-title":"N Engl J Med"},{"key":"897_CR35","doi-asserted-by":"crossref","first-page":"177A","DOI":"10.1016\/0300-9572(92)90057-J","volume":"24","author":"Colquhoun","year":"1992","unstructured":"Colquhoun MC, Julien DG (1992) Sudden death in the community: the arrhythmia causing cardiac arrest and results of immediate resuscitation. Resuscitation 24:177A","journal-title":"Resuscitation"},{"key":"897_CR36","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)02225-X","volume":"355","author":"Dahlback","year":"2000","unstructured":"Dahlback B (2000) Blood coagulation. Lancet 355:1627\u20131632","journal-title":"Lancet"},{"key":"897_CR37","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1161\/01.CIR.0000091088.63921.8C","volume":"108","author":"Dalby","year":"2003","unstructured":"Dalby M, Bouzamondo A, Lechat P, Montalescot G (2003) Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation 108:1809\u20131814","journal-title":"Circulation"},{"key":"897_CR38","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/heart.83.3.361","volume":"83","author":"Davies","year":"2000","unstructured":"Davies MJ (2000) The pathophysiology of acute coronary syndromes. Heart 83:361\u2013366","journal-title":"Heart"},{"key":"897_CR39","doi-asserted-by":"crossref","first-page":"645","DOI":"10.7326\/0003-4819-126-8-199704150-00010","volume":"126","author":"Dracup","year":"1997","unstructured":"Dracup K, Alonzo AA, Atkins JM et al. (1997) The physician\u2019s role in minimizing prehospital delay in patients at high risk for acute myocardial infarction: recommendations from the National Heart Attack Alert Program. Working Group on Educational Strategies to Prevent Prehospital Delay in Patients at High Risk for Acute Myocardial Infarction. Ann Intern Med 126:645\u2013651","journal-title":"Ann Intern Med"},{"key":"897_CR40","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0140-6736(00)02324-2","volume":"355","author":"Eikelboom","year":"2000","unstructured":"Eikelboom JW, Anand SS, Malmberg K, Weitz JI, Ginsberg JS, Yusuf S (2000) Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis. Lancet 355:1936\u20131942","journal-title":"Lancet"},{"key":"897_CR41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/hrt.38.4.415","volume":"38","author":"El-Sherif","year":"1976","unstructured":"El-Sherif N, Myerburg RJ, Scherlag BJ, Befeler B, Aranda JM, Castellanos A, Lazzara R (1976) Electrocardiographic antecedents of primary ventricular fibrillation: value of the R-on-T phenomenon in myocardial infarction. Br Heart J 38:415\u2013422","journal-title":"Br Heart J"},{"key":"897_CR42","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJM199308053290602","volume":"329","author":"European","year":"1993","unstructured":"European Myocardial Infarction Project Group (1993) (EMIP) Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 329:383\u2013389","journal-title":"N Engl J Med"},{"key":"897_CR43","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/01.CIR.71.4.699","volume":"71","author":"Falk","year":"1985","unstructured":"Falk E (1985) Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and\/or sudden death: autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 71:699\u2013708","journal-title":"Circulation"},{"key":"897_CR44","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1161\/01.CIR.92.7.1701","volume":"92","author":"Farb","year":"1995","unstructured":"Farb A, Tang AL, Burke AP, Sessums L, Liang Y, Virmani R (1995) Sudden coronary death: frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. Circulation 92:1701\u20131709","journal-title":"Circulation"},{"key":"897_CR45","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(94)91161-4","volume":"343","author":"Fibrinolytic","year":"1994","unstructured":"Fibrinolytic Trialists Collaborative Group (FTT) (1994) Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 343:311\u2013322","journal-title":"Lancet"},{"key":"897_CR46","first-page":"32","volume":"13","author":"Fresco","year":"1990","unstructured":"Fresco C, Franzosi MG, Maggioni AP, Tognoni G (1990) The GISSI-2 trial: premises, results, epidemiological (and other) implications Gruppo Italiano per lo Studio delia Sopravvivenza nell\u2019Infarto Miocardico. Clin Cardiol 13:32\u201336","journal-title":"Clin Cardiol"},{"key":"897_CR47","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(96)91270-2","volume":"347","author":"FRISC","year":"1996","unstructured":"FRISC study group (1996) Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group. Lancet 347:561\u2013568","journal-title":"Lancet"},{"key":"897_CR48","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/01.CIR.92.5.1326","volume":"92","author":"Furberg","year":"1995","unstructured":"Furberg CD, Psaty BM, Mayer JV (1995) Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 92:1326\u20131331","journal-title":"Circulation"},{"key":"897_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0883-9441(95)90024-1","volume":"10","author":"Garber","year":"1995","unstructured":"Garber PJ, Gu S, Ducas J, Schick U, Prewitt RM (1995) An increase in low aortic pressure increases coronary artery flow and coronary thrombolysis induced by intravenous administration of recombinant tissue plasminogen activator. J Crit Care 10:1\u20136","journal-title":"J Crit Care"},{"key":"897_CR50","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0002-8703(84)90558-1","volume":"108","author":"Gillum","year":"1984","unstructured":"Gillum RF, Fortmann SP, Prineas RJ, Kottke TE (1984) International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J 108:150\u2013158","journal-title":"Am Heart J"},{"key":"897_CR51","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1001\/archinte.1995.00430140035003","volume":"155","author":"GISSI-Avoidable","year":"1995","unstructured":"GISSI-Avoidable Delay Study Group (1995) Epidemiology of avoidable delay in the care of patients with acute myocardial infarction in Italy. A GISSI-generated study. Arch Intern Med 155:1481\u20131488","journal-title":"Arch Intern Med"},{"key":"897_CR52","first-page":"1115","volume":"343","author":"GISSI-3","year":"1994","unstructured":"GISSI-3 (1994) Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction: Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019infarto Miocardico. Lancet 343:1115\u20131122","journal-title":"Lancet"},{"key":"897_CR53","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/bmj.305.6853.548","volume":"305","author":"GREAT","year":"1992","unstructured":"GREAT Group (1992) Feasibility, safety and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. BMJ 305:548\u2013553","journal-title":"BMJ"},{"key":"897_CR54","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/oxfordjournals.eurheartj.a060914","volume":"16","author":"Grijseels","year":"1995","unstructured":"Grijseels EW, Deckers JW, Hoes AW, Hartman JA, Does E van der, Loenen E van, Simoons ML (1995) Pre-hospital triage of patients with suspected myocardial infarction. Evaluation of previously developed algorithms and new proposals. Eur Heart J 16:325\u2013332","journal-title":"Eur Heart J"},{"key":"897_CR55","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1399-6576.1998.tb05134.x","volume":"42","author":"Gust","year":"1998","unstructured":"Gust R, Gust A, B\u00f6ttiger BW, B\u00f6hrer H, Martin E (1998) Bedside troponin T testing is not useful for early out-of-hospital diagnosis of myocardial infarction. Acta Anesthesiol Scand 42:414\u2013417","journal-title":"Acta Anesthesiol Scand"},{"key":"897_CR56","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","volume":"329","author":"GUSTO","year":"1993","unstructured":"GUSTO Investigators (1993) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329:673\u2013682","journal-title":"N Engl J Med"},{"key":"897_CR57","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJM199710163371603","volume":"337","author":"GUSTO","year":"1997","unstructured":"GUSTO III: The Global Use of Strategies to Open Occluded Coronary Arteries Investigators (1997) A comparsion of reteplase with alteplase for acute myocardial infarction. N Engl J Med 337:1118\u20131123","journal-title":"N Engl J Med"},{"key":"897_CR58","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0140-6736(01)06585-0","volume":"358","author":"Hamm","year":"2001","unstructured":"Hamm CW, Bertrand M, Braunwald E (2001) Acute coronary syndrome without ST elevation: implementation of new guidelines. Lancet 358:1533\u20131538","journal-title":"Lancet"},{"key":"897_CR59","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00392-004-1064-2","volume":"93","author":"Hamm","year":"2004","unstructured":"Hamm CW, Arntz HR, Bode C et al. (2004) Leitlinien. Akutes Koronarsyndrom. Teil 1: ACS ohne persistierende ST-Hebung. Z Kardiol 93:72\u201390","journal-title":"Z Kardiol"},{"key":"897_CR60","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00392-004-0109-x","volume":"93","author":"Hamm","year":"2004","unstructured":"Hamm CW, Arntz HR, Bode C et al. (2004) Leitlinien. Akutes Koronarsyndrom. Teil 2: ACS mit persistierender ST-Hebung. Z Kardiol 93:324\u2013341","journal-title":"Z Kardiol"},{"key":"897_CR61","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","volume":"341","author":"Hochman","year":"1999","unstructured":"Hochman JS, Sleeper LA, Webb JG et al. (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 341:625\u2013634","journal-title":"N Engl J Med"},{"key":"897_CR62","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jama.285.2.190","volume":"285","author":"Hochman","year":"2001","unstructured":"Hochman JS, Sleeper LA, White HD et al. (2001) One-year survival following early revascularization for cardiogenic shock. JAMA 285:190\u2013192","journal-title":"JAMA"},{"key":"897_CR63","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0002-9149(98)00964-3","volume":"83","author":"Holmvang","year":"1999","unstructured":"Holmvang L, Andersen K, Dellborg AK et al. (1999) Relative contributions of a single-admission 12-lead electrocardiogram and early 24-hour continuous electrocardiographic monitoring for early risk stratification in patients with unstable coronary artery disease. Am J Cardiol 83:667\u2013674","journal-title":"Am J Cardiol"},{"key":"897_CR64","first-page":"921","volume":"1","author":"ISIS-1","year":"1988","unstructured":"ISIS-1 (1988) Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Lancet 1:921\u2013923","journal-title":"Lancet"},{"key":"897_CR65","first-page":"349","volume":"2","author":"ISIS-2","year":"1988","unstructured":"ISIS-2 (1988) Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 2:349\u2013360","journal-title":"Lancet"},{"key":"897_CR66","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0140-6736(92)91893-D","volume":"339","author":"ISIS-3","year":"1992","unstructured":"ISIS-3 (Third International Study on Infarct Survival) Collaborative Group (1992) A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreptase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 339:753\u2013770","journal-title":"Lancet"},{"key":"897_CR67","first-page":"669","volume":"345","author":"ISIS-4","year":"1994","unstructured":"ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group (1994) ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 345:669\u2013685","journal-title":"Lancet"},{"key":"897_CR68","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/euhj.2000.2305","volume":"21","author":"Joint","year":"2000","unstructured":"Joint European Society of Cardiology\/American College of Cardiology Commitee (2000) Myocardial infarction redefined \u2014 A consensus document of the Joint European Society of Cardiology\/American College of Cardiology for the redefinition of myocardial infarction. Eur Heart J 21:1502\u20131513","journal-title":"Eur Heart J"},{"key":"897_CR69","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/01.CIR.59.3.607","volume":"59","author":"Joint","year":"1979","unstructured":"Joint International Society and Federation of Cardiology\/World Health Organization Task Force on standardization of clinical nomenclature (1979) Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 59:607\u2013609","journal-title":"Circulation"},{"key":"897_CR70","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/01.CIR.78.4.906","volume":"78","author":"Jugdutt","year":"1988","unstructured":"Jugdutt BI, Warnica JW (1988) Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications: effect of timing, dosage, and infarct location. Circulation 78:906\u2013919","journal-title":"Circulation"},{"key":"897_CR71","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0002-9149(98)00858-3","volume":"83","author":"Juliard","year":"1999","unstructured":"Juliard JM, Himbert D, Cristofini P et al. (1999) A matched comparison of the combination of rehospital thrombolysis and standby rescue angioplasty with primary angioplasty. Am J Cardiol 83:305\u2013310","journal-title":"Am J Cardiol"},{"key":"897_CR72","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/0002-9149(90)90352-2","volume":"66","author":"Karagounis","year":"1990","unstructured":"Karagounis L, Ipsen SK, Jessop MR et al. (1990) Impact of field-transmitted electrocardiography on time to in-hospital thrombolytic therapy in acute myocardial infarction. Am J Cardiol 66:786\u2013791","journal-title":"Am J Cardiol"},{"key":"897_CR73","first-page":"484","volume":"48","author":"Kharb","year":"2000","unstructured":"Kharb S, Singh V (2000) Magnesium deficiency potentiates free radical production associated with myocardial infarction. J Assoc Physicians India 48:484\u2013485","journal-title":"J Assoc Physicians India"},{"key":"897_CR74","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","volume":"361","author":"Keeley","year":"2003","unstructured":"Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361:13\u201320","journal-title":"Lancet"},{"key":"897_CR75","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0002-8703(92)90684-N","volume":"123","author":"Kereiakes","year":"1992","unstructured":"Kereiakes DJ, Gibler WB, Martin LH, Pieper KS, Anderson LC (1992) Relative importance of emergency medical system transport and the prehospital electrocardiogram on reducing hospital time delay to therapy for acute myocardial infarction: a preliminary report from the Cincinnati Heart Project. Am Heart J 123:835\u2013840","journal-title":"Am Heart J"},{"key":"897_CR76","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s003920050517","volume":"87","author":"Koenig","year":"1998","unstructured":"Koenig W (1998) Epidemiology of coronary heart disease. Z Kardiol 87:3\u20137","journal-title":"Z Kardiol"},{"key":"897_CR77","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/0735-1097(91)90636-N","volume":"17","author":"Kudenchuk","year":"1991","unstructured":"Kudenchuk PJ, Ho MT, Weaver WD et al. (1991) Accuracy of computer-interpreted electrocardiography in selecting patients for thrombolytic therapy. MITI Project Investigators. J Am Coll Cardiol 17:1486\u20131491","journal-title":"J Am Coll Cardiol"},{"key":"897_CR78","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/oxfordjournals.eurheartj.a061020","volume":"16","author":"Larsson","year":"1995","unstructured":"Larsson H, Areskog M, Areskog NH, Jonasson T, Ringqvist I, Fellenius C, Wallentin L (1995) The diagnostic and prognostic importance of ambulatory ST recording compared to a predischarge exercise test after an episode of unstable angina or non-Q wave myocardial infarction. Eur Heart J 16:888\u2013893","journal-title":"Eur Heart J"},{"key":"897_CR79","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1161\/01.CIR.92.10.3132","volume":"92","author":"Latini","year":"1995","unstructured":"Latini R, Maggioni AP, Flather M, Sleight P, Tognoni G (1995) ACE-inhibitor use in patients with myocardial infarction: summary of evidence from clinical trials. Circulation 92:3132\u20133137","journal-title":"Circulation"},{"key":"897_CR80","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0300-9572(00)00379-8","volume":"48","author":"Latorre","year":"2001","unstructured":"Latorre F de, Nolan J, Robertson C, Chamberlain D, Baskett P (2001) European Resuscitation Council Guidelines 2000 for Adult Advanced Life Support. Resuscitation 48:211\u2013221","journal-title":"Resuscitation"},{"key":"897_CR81","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0300-9572(01)00317-3","volume":"50","author":"Lederer","year":"2001","unstructured":"Lederer W, Lichtenberger C, Pechlaner C, Kroesen G, Baubin M (2001) Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest. Resuscitation 50:71\u201376","journal-title":"Resuscitation"},{"key":"897_CR82","first-page":"311","volume":"343","author":"Leizorovicz","year":"1997","unstructured":"Leizorovicz A, Haugh MC, Mercier C, Boissel JP on behalf of the EMIP Group (1997) Pre-hospital and hospital. Lancet 343:311\u2013322","journal-title":"Lancet"},{"key":"897_CR83","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.CIR.104.3.365","volume":"104","author":"Libby","year":"2001","unstructured":"Libby P (2001) Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104:365\u2013372","journal-title":"Circulation"},{"key":"897_CR84","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1161\/01.CIR.52.5.755","volume":"52","author":"Lie","year":"1975","unstructured":"Lie KI, Wellens HJ, Downar E, Durrer D (1975) Observations on patients with primary ventricular fibrillation complicating acute myocardial infarction. Circulation 52:755\u2013759","journal-title":"Circulation"},{"key":"897_CR85","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s003900050358","volume":"36","author":"L","year":"1999","unstructured":"L\u00f6wel H, Engel S, H\u00f6rmann A, Gostomzyk J, Bolte HD, Keil U f\u00fcr das MONICA-Augsburg Herzinfarktregisterteam (1999) Notfallmedizin: Akuter Herzinfarkt und pl\u00f6tzlicher Herztod aus epidemiologischer Sicht. Intensivmedizin 36:652\u2013661","journal-title":"Intensivmedizin"},{"key":"897_CR86","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/01.STR.24.4.587","volume":"24","author":"Longstreth","year":"1993","unstructured":"Longstreth WT Jr, Litwin PE, Weaver WD (1993) Myocardial infarction, thrombolytic therapy, and stroke. A community-based study. The MITI Project Group. Stroke 24:587\u2013590","journal-title":"Stroke"},{"key":"897_CR87","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1053\/euhj.2000.2500","volume":"22","author":"Loubeyre","year":"2001","unstructured":"Loubeyre C, Lefevre T, Louvard Y et al. (2001) Outcome after combined reperfusion therapy for acute myocardial infarction, combining pre-hospital thrombolysis with immediate percutaneous coronary intervention and stent. Eur Heart J 22:1128\u20131135","journal-title":"Eur Heart J"},{"key":"897_CR88","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s003920050179","volume":"4","author":"Luiz","year":"1998","unstructured":"Luiz T, Ellinger K, Budde A, Hechler C, Klar H, Riester T (1998) Evaluierung eines qualitativen Schnelltestes f\u00fcr kardiales Troponin T zur pr\u00e4klinischen Diagnostik bei Patienten mit akutem Koronarsyndrom. Z Kardiol 4:267\u2013275","journal-title":"Z Kardiol"},{"key":"897_CR89","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.CIR.53.3.411","volume":"53","author":"Madias","year":"1976","unstructured":"Madias JE, Madias NE, Hood WB Jr (1976) Precordial ST-segment mapping, II: effects of oxygen inhalation on ischemic injury in patients with acute myocardial infarction. Circulation 53:411\u2013417","journal-title":"Circulation"},{"key":"897_CR90","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1161\/01.CIR.52.3.360","volume":"52","author":"Maroko","year":"1975","unstructured":"Maroko PR, Radvany P, Braunwald E, Hale SL (1975) Reduction of infarct size by oxygen inhalation following acute coronary occlusion. Circulation 52:360\u2013368","journal-title":"Circulation"},{"key":"897_CR91","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0008-6363(02)00253-5","volume":"54","author":"Matsusaka","year":"2002","unstructured":"Matsusaka T, Hasebe N, Jin YT, Kawabe J, Kikuchi K (2002) Magnesium reduces myocardial infarct size via enhancement of adenosine mechanism in rabbits. Cardiovasc Res 54:568\u2013575","journal-title":"Cardiovasc Res"},{"key":"897_CR92","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/S0735-1097(99)00038-8","volume":"33","author":"Merkhof","year":"1999","unstructured":"Merkhof LF van den, Zijlstra F, Olsson H et al. (1999) Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the Glycoprotein Receptor Antagonist Patency Evaluation (GRAPE) Pilot Study. J Am Coll Cardiol 33:1528\u20131532","journal-title":"J Am Coll Cardiol"},{"key":"897_CR93","doi-asserted-by":"crossref","first-page":"1G","DOI":"10.1016\/0002-9149(85)90688-5","volume":"56","author":"MIAMI","year":"1985","unstructured":"MIAMI Trial Research Group (1985) Metoprolol in acute myocardial infarction: patient population. Am J Cardiol 56:1G\u201357G","journal-title":"Am J Cardiol"},{"key":"897_CR94","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJM200106213442503","volume":"344","author":"Montalescot","year":"2001","unstructured":"Montalescot G, Barragan P, Wittenberg O et al. (2001) Platelet glycoprotein IIb\/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 344:1895\u20131903","journal-title":"N Engl J Med"},{"key":"897_CR95","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1001\/jama.283.20.2686","volume":"283","author":"Morrison","year":"2000","unstructured":"Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ (2000) Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis. JAMA 283:2686\u20132692","journal-title":"JAMA"},{"key":"897_CR96","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0735-1097(02)01936-8","volume":"40","author":"Morrow","year":"2002","unstructured":"Morrow DA, Antman EM, Sayah A et al. (2002) Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 Trial. J Am Coll Cardiol 40:71\u201377","journal-title":"J Am Coll Cardiol"},{"key":"897_CR97","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0002-9149(03)00891-9","volume":"92","author":"Nallamothu","year":"2003","unstructured":"Nallamothu B, Bates ER (2003) Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol 92:824\u2013826","journal-title":"Am J Cardiol"},{"key":"897_CR98","first-page":"58","volume":"13","author":"National","year":"1995","unstructured":"National Heart Attack Alert Program Coordinating Committee Access to Care Subcommittee (1995) Staffing and equipping emergency medical services system: rapid identification and treatment of acute myocardial infarction. Am J Emerg Med 13:58\u201366","journal-title":"Am J Emerg Med"},{"key":"897_CR99","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1008820104852","volume":"6","author":"National","year":"1998","unstructured":"National Heart Attack Alert Program Coordinating Committee (1998) Access to timely and optimal care of patients with acute coronary syndromes \u2014 Community planning considerations: a report by the National Heart Attack Alert Program. J Thromb Thrombolysis 6:19\u201347","journal-title":"J Thromb Thrombolysis"},{"key":"897_CR100","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/0735-1097(89)90399-9","volume":"14","author":"Neuhaus","year":"1989","unstructured":"Neuhaus KL, Feuerer W, Jeep-Tebbe S, Niederer W, Vogt A, Tebbe U (1989) Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator. J Am Coll Cardiol 14:1566\u20131569","journal-title":"J Am Coll Cardiol"},{"key":"897_CR101","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0196-0644(00)70008-4","volume":"35","author":"Newman","year":"2000","unstructured":"Newman DH, Greenwald I, Callaway CW (2000) Cardiac arrest and the role of thrombolytic agents. Ann Emerg Med 35:472\u2013480","journal-title":"Ann Emerg Med"},{"key":"897_CR102","first-page":"1065","volume":"316","author":"Norris","year":"1998","unstructured":"Norris RM (1998) Fatality outside hospital from acute coronary events in three British districts, 1994\u20135. United Kingdom Heart Attack Study Collaborative Group. BMJ 316:1065\u20131070","journal-title":"BMJ"},{"key":"897_CR103","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1136\/bmj.286.6375.1405","volume":"286","author":"O","year":"1983","unstructured":"O\u2019Doherty M, Taylor DI, Quinn E, Vincent R, Chamberlain DA (1983) Five hundred patients with myocardial infarction monitored within one hour of symptoms. BMJ 286:1405\u20131408","journal-title":"BMJ"},{"key":"897_CR104","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jama.1996.03540100055028","volume":"276","author":"Oler","year":"1996","unstructured":"Oler A, Whooley MA, Oler J, Grady D (1996) Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis. JAMA 276:811\u2013815","journal-title":"JAMA"},{"key":"897_CR105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(67)90110-9","volume":"2","author":"Pantridge","year":"1967","unstructured":"Pantridge JF, Geddes JS (1967) A mobile intensive-care unit in the management of myocardial infarction. Lancet 2:271\u2013273","journal-title":"Lancet"},{"key":"897_CR106","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/01.CIR.97.24.2386","volume":"97","author":"PARAGON","year":"1998","unstructured":"PARAGON Investigators (1998) International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb\/IIIa inhibitor), heparin, or both in unstable angina. Circulation 97:2386\u20132395","journal-title":"Circulation"},{"key":"897_CR107","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/hrt.75.3.222","volume":"75","author":"Patel","year":"1996","unstructured":"Patel DJ, Holdright DR, Knight CJ et al. (1996) Early continuous ST segment monitoring in unstable angina: prognostic value additional to the clinical characteristics and the admission electrocardiogram. Heart 75:222\u2013228","journal-title":"Heart"},{"key":"897_CR108","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0735-1097(92)90241-E","volume":"20","author":"Popma","year":"1992","unstructured":"Popma JJ, Califf RM, Ellis SG et al. (1992) Mechanism of benefit of combination thrombolytic therapy for acute myocardial infarction: a quantitative angiographic and hematologic study. J Am Coll Cardiol 20:1305\u20131312","journal-title":"J Am Coll Cardiol"},{"key":"897_CR109","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/01.CIR.90.2.800","volume":"90","author":"Popovic","year":"1994","unstructured":"Popovic AD, Neskovic AN, Babic R et al. (1994) Independent impact of thrombolytic therapy and vessel patency on left ventricular dilation after myocardial infarction. Serial echocardiographic follow-up. Circulation 90:800\u2013807","journal-title":"Circulation"},{"key":"897_CR110","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1056\/NEJM199805213382103","volume":"338","author":"PRISM","year":"1998","unstructured":"PRISM Investigators (1998) A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med 338:1498\u20131505","journal-title":"N Engl J Med"},{"key":"897_CR111","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","volume":"338","author":"PRISM-PLUS","year":"1998","unstructured":"PRISM-PLUS Investigators (1998) Inhibition of the platelet glycoprotein IIb\/IIIa with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 338:1488\u20131497","journal-title":"N Engl J Med"},{"key":"897_CR112","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","volume":"339","author":"PURSUIT","year":"1998","unstructured":"PURSUIT Investigators (1998) Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet glycoprotein IIb\/IIIa in unstable angina: receptor suppression using integrilin therapy. N Engl J Med 339:436\u2013443","journal-title":"N Engl J Med"},{"key":"897_CR113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0735-1097(88)90158-1","volume":"11","author":"Rao","year":"1988","unstructured":"Rao AK, Pratt C, Berke A et al. (1988) Thrombolysis in Myocardial Infarction (TIMI) Trial-phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 11:1\u201311","journal-title":"J Am Coll Cardiol"},{"key":"897_CR114","unstructured":"Rat der Europ\u00e4ischen Gemeinschaften (1991) Entscheidung des Rates vom 29. Juli 1991 zur Einf\u00fchrung einer einheitlichen europ\u00e4ischen Notrufnummer (91\/396\/EWG). Amtsblatt der Europ\u00e4ischen Gemeinschaften L 217\/31 (6\u20138-91)"},{"key":"897_CR115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0735-1097(94)90494-4","volume":"23","author":"Rawles","year":"1994","unstructured":"Rawles J (1994) Halving of mortality at 1\u00a0year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT). J Am Coll Cardiol 23:1\u20135","journal-title":"J Am Coll Cardiol"},{"key":"897_CR116","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/heart.89.5.563","volume":"89","author":"Rawles","year":"2003","unstructured":"Rawles J (2003) GREAT: 10\u00a0year survival of patients with suspected acute myocardial infarction in a randomised comparison of prehospital and hospital thrombolysis. Heart 89:563\u2013564","journal-title":"Heart"},{"key":"897_CR117","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1161\/01.CIR.56.5.786","volume":"56","author":"Reimer","year":"1977","unstructured":"Reimer KA, Lowe JE, Rasmussen MM, Jennings RB (1977) The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 56:786\u2013794","journal-title":"Circulation"},{"key":"897_CR118","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)92336-G","volume":"336","author":"RISC","year":"1990","unstructured":"RISC Group (1990) Risc of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 336:827\u2013830","journal-title":"Lancet"},{"key":"897_CR119","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0300-9572(98)00035-5","volume":"37","author":"Robertson","year":"1998","unstructured":"Robertson C, Stehen P, Adgey J et al. (1998) The 1998 European Resuscitation Council guidelines for adult advanced life support. Resuscitation 37:81\u201390","journal-title":"Resuscitation"},{"key":"897_CR120","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJM199905203402007","volume":"340","author":"Rosenberg","year":"1999","unstructured":"Rosenberg RD, Aird WC (1999) Vascular-bed: specific hemostasis and hypercoagulable states. N Engl J Med 340:1555\u20131564","journal-title":"N Engl J Med"},{"key":"897_CR121","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/S0735-1097(99)00444-1","volume":"34","author":"Ross","year":"1999","unstructured":"Ross AM, Coyne KS, Reiner JS et al. (1999) A randomized trial comparing primary angioplasty with a strategy of short acting thrombolysis and immediate planned rescue angiolasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial. J Am Coll Cardiol 34:1954\u20131962","journal-title":"J Am Coll Cardiol"},{"key":"897_CR122","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ahj.2004.11.006","volume":"149","author":"Sabatine","year":"2005","unstructured":"Sabatine MS, McCabe CH, Gibson CM, Cannon CP (2005) Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial. Am Heart J 149:227\u2013233","journal-title":"Am Heart J"},{"key":"897_CR123","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/jama.281.8.707","volume":"281","author":"Savonitto","year":"1999","unstructured":"Savonitto S, Ardissino D, Granger CB et al. (1999) Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA 281:707\u2013713","journal-title":"JAMA"},{"key":"897_CR124","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0002-9149(99)80546-3","volume":"75","author":"Shechter","year":"1995","unstructured":"Shechter M, Hod H, Chouraqui P, Kaplinsky E, Rabinowitz B (1995) Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy. Am J Cardiol 75:321\u2013323","journal-title":"Am J Cardiol"},{"key":"897_CR125","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/0002-9149(90)90528-9","volume":"66","author":"Schofer","year":"1990","unstructured":"Schofer J, Buttner J, Geng G et al. (1990) Prehospital thrombolysis in acute myocardial infarction. Am J Cardiol 66:1429\u20131433","journal-title":"Am J Cardiol"},{"key":"897_CR126","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/0002-9149(92)90494-J","volume":"69","author":"Scholz","year":"1992","unstructured":"Scholz KH, Tebbe U, Hermann G, Woijcik J, Lingen JM, Chemnitius JM (1992) Frequency of complications of cardiopulmonary resuscitation after thrombolysis during acute myocardial infarction. Am J Cardiol 69:724\u2013728","journal-title":"Am J Cardiol"},{"key":"897_CR127","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0002-8703(99)70244-9","volume":"138","author":"Schuchert","year":"1999","unstructured":"Schuchert A, Hamm C, Scholz J, Klimmeck S, Goldmann B, Meinertz T (1999) Prehospital testing for troponin T in patients with suspected acute myocardial infarction. Am Heart J 138:45\u201348","journal-title":"Am Heart J"},{"key":"897_CR128","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0140-6736(05)80089-3","volume":"342","author":"Simoons","year":"1993","unstructured":"Simoons ML, Maggioni AP, Knatterud G et al. (1993) Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet 342:1523\u20131528","journal-title":"Lancet"},{"key":"897_CR129","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/eurheartj\/15.suppl_B.14","volume":"15","author":"Sigurdsson","year":"1994","unstructured":"Sigurdsson A, Swedberg K (1994) Left ventricular remodelling, neurohormonal activation and early treatment with enalapril (CONSENSUS II) following myocardial infarction. Eur Heart J 15:14\u201319","journal-title":"Eur Heart J"},{"key":"897_CR130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2796.1991.tb00355.x","volume":"229","author":"Silfvast","year":"1991","unstructured":"Silfvast T (1991) Cause of death in unsuccessful prehospital resuscitation. J Intern Med 229:331\u2013335","journal-title":"J Intern Med"},{"key":"897_CR131","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJM199706053362302","volume":"336","author":"Spaulding","year":"1997","unstructured":"Spaulding CM, Joly LM, Rosenberg A, Monchi M, Weber SN, Dhainaut JF, Carli P (1997) Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med 336:1629\u20131633","journal-title":"N Engl J Med"},{"key":"897_CR132","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1161\/01.CIR.0000103122.10021.F2","volume":"108","author":"Steg","year":"2003","unstructured":"Steg PG, Bonnefoy E, Chaubaud S et al. (2003) Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty. Circulation 108:2851\u20132856","journal-title":"Circulation"},{"key":"897_CR133","unstructured":"Statistisches Bundesamt (2002) Gesundheitswesen: Todesursachen in Deutschland. Fachserie 12\/ Reihe 4"},{"key":"897_CR134","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/euhj.1998.1106","volume":"19","author":"Task","year":"1998","unstructured":"Task Force Report (1998) The pre-hospital management of acute heart attacks. Eur Heart J 19:1140\u20131164","journal-title":"Eur Heart J"},{"key":"897_CR135","first-page":"43","volume":"17","author":"Task","year":"1996","unstructured":"Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology (1996) Acute myocardial infarction: pre-hospital and in-hospital management. Eur Heart J 17:43\u201363","journal-title":"Eur Heart J"},{"key":"897_CR136","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/01.CIR.88.5.2045","volume":"88","author":"Theroux","year":"1993","unstructured":"Theroux P, Waters D, Qiu S, McCans J, Guise P de, Juneau M (1993) Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation 88:2045\u20132048","journal-title":"Circulation"},{"key":"897_CR137","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJM198903093201002","volume":"320","author":"TIMI","year":"1989","unstructured":"TIMI Study Group (1989) Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the thrombolysis in myocardial infarction (TIMI) phase II trial. N Engl J Med 320:618\u2013627","journal-title":"N Engl J Med"},{"key":"897_CR138","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1161\/01.CIR.101.19.2239","volume":"101","author":"Thiemann","year":"2000","unstructured":"Thiemann DR, Coresh J, Schulman SP, Gerstenblith G, Oetjen WJ, Powe NR (2000) Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation 101:2239","journal-title":"Circulation"},{"key":"897_CR139","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0735-1097(98)00094-1","volume":"31","author":"Tiefenbrunn","year":"1998","unstructured":"Tiefenbrunn AJ, Chandra NC, French WJ et al. (1998) Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 31:1240\u20131245","journal-title":"J Am Coll Cardiol"},{"key":"897_CR140","first-page":"633","volume":"78","author":"Trappe","year":"1989","unstructured":"Trappe HJ, Brugada P, Lezaun R, Wellens HJ (1989) The significance of ventricular tachycardia morphology for prognosis and follow-up. Z Kardiol 78:633\u2013639","journal-title":"Z Kardiol"},{"key":"897_CR141","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0140-6736(99)04021-0","volume":"353","author":"Tunstall-Pedoe","year":"1999","unstructured":"Tunstall-Pedoe H, Kuulasmaa K, Mahonen M et al. (1999) Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 353:1547\u20131557","journal-title":"Lancet"},{"key":"897_CR142","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1053\/euhj.1998.1353","volume":"20","author":"Urban","year":"1999","unstructured":"Urban P, Stauffer JC, Bleed D et al. (1999) A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH. Eur Heart J 20:1030\u20131038","journal-title":"Eur Heart J"},{"key":"897_CR143","first-page":"267","volume":"43","author":"Virmani","year":"1998","unstructured":"Virmani R, Burke AP, Farb A (1998) Plaque morphology in sudden coronary death. Cardiologia 43:267\u2013271","journal-title":"Cardiologia"},{"key":"897_CR144","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.CIR.0000081659.72985.A8","volume":"108","author":"Wallentin","year":"2003","unstructured":"Wallentin L, Goldstein P, Armstrong PW et al. (2003) Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting (ASSENT 3 Plus). Circulation 108:135\u2013142","journal-title":"Circulation"},{"key":"897_CR145","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/0735-1097(95)00108-G","volume":"25","author":"Weaver","year":"1995","unstructured":"Weaver WD (1995) Time to thrombolytic treatment: factors affecting delay and their influence on outcome. J Am Coll Cardiol 25:3S\u20139S","journal-title":"J Am Coll Cardiol"},{"key":"897_CR146","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1001\/jama.1993.03510100061033","volume":"270","author":"Weaver","year":"1993","unstructured":"Weaver WD, Cerqueira M, Hallstrom AP, Litwin PE, Martin JS, Kudenchuk PJ, Eisenberg M (1993) Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA 270:1211\u20131216","journal-title":"JAMA"},{"key":"897_CR147","first-page":"28","volume":"24","author":"Werf","year":"2003","unstructured":"Werf F van de, Ardissino D, Betriu A et al. (2003) Management of acute myocardial infarction in patients presenting with ST-segment elevation. Task Force of the ESC. Eur Heart J 24:28\u201366","journal-title":"Eur Heart J"},{"key":"897_CR148","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0140-6736(05)74481-0","volume":"356","author":"White","year":"2000","unstructured":"White HD (2000) Thrombolytic therapy in the elderly. Lancet 356:228\u2013230","journal-title":"Lancet"},{"key":"897_CR149","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0195-668X(02)00468-2","volume":"24","author":"Widimsky","year":"2003","unstructured":"Widimsky P, Budesinsky T, Vorac D et al. \u201ePRAGUE\u201c Study Group Investigators (2003) Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial \u2014 PRAGUE-2. Eur Heart J 24:94\u2013104","journal-title":"Eur Heart J"},{"key":"897_CR150","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/0140-6736(92)91828-V","volume":"339","author":"Woods","year":"1992","unstructured":"Woods KL, Fletcher S, Roffe C, Haider Y (1992) Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 339:1553\u20131558","journal-title":"Lancet"},{"key":"897_CR151","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","volume":"27","author":"Yusuf","year":"1985","unstructured":"Yusuf S, Peto R, Lewis J, Collins R, Sleight P (1985) Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 27:335\u2013371","journal-title":"Prog Cardiovasc Dis"},{"key":"897_CR152","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S0140-6736(88)91906-X","volume":"1","author":"Yusuf","year":"1988","unstructured":"Yusuf S, MacMahon S, Collins R, Peto R (1988) Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials. Lancet 1:1088\u20131092","journal-title":"Lancet"},{"key":"897_CR153","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/0002-9149(91)90944-G","volume":"67","author":"Yusuf","year":"1991","unstructured":"Yusuf S, Held P, Furberg C (1991) Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies. Am J Cardiol 67:1295\u20131297","journal-title":"Am J Cardiol"},{"key":"897_CR154","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00004872-199306003-00013","volume":"11","author":"Yusuf","year":"1993","unstructured":"Yusuf S, Lessem J, Jha O et al. (1993) Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated controlled trials. J Hypertens Suppl 11:61\u201373","journal-title":"J Hypertens Suppl"},{"key":"897_CR155","doi-asserted-by":"crossref","unstructured":"Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 345:494\u2013502","DOI":"10.1056\/NEJMoa010746"},{"key":"897_CR156","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199911043411901","volume":"341","author":"Zijlstra","year":"1999","unstructured":"Zijlstra F, Hoorntje JC, Boer MJ de et al. (1999) Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 341:1413\u20131419","journal-title":"N Engl J Med"},{"key":"897_CR157","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1161\/01.CIR.98.21.2334","volume":"98","author":"Zipes","year":"1998","unstructured":"Zipes DP, Wellens HJ (1998) Sudden cardiac death. Circulation 98:2334\u20132351","journal-title":"Circulation"}],"container-title":["Der Anaesthesist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-005-0897-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00101-005-0897-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-005-0897-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T02:04:36Z","timestamp":1586397876000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00101-005-0897-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":157,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["897"],"URL":"https:\/\/doi.org\/10.1007\/s00101-005-0897-z","relation":{},"ISSN":["0003-2417","1432-055X"],"issn-type":[{"value":"0003-2417","type":"print"},{"value":"1432-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}